SGLT2 Inhibitors and Blood Pressure in Heart Failure: A Misunderstanding of Our Understanding?

JACC Heart Fail. 2023 Jan;11(1):90-92. doi: 10.1016/j.jchf.2022.10.009. Epub 2022 Dec 7.

Authors

Amrut V Ambardekar¹, Christine Sailer²

Affiliations

¹ Department of Medicine, Division of Cardiology, and the Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: Amrut.Ambardekar@cuanschutz.edu.
² Department of Medicine, Division of Cardiology, and the Consortium for Fibrosis Research and Translation, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

PMID: 36599554
DOI: 10.1016/j.jchf.2022.10.009

No abstract available

Keywords: heart failure with preserved ejection fraction; hypertension; sodium-glucose cotransporter 2 inhibitors.

Publication types

Editorial
Comment

MeSH terms

Blood Pressure
Heart Failure* / drug therapy
Humans
Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Stroke Volume

Substances

Sodium-Glucose Transporter 2 Inhibitors